1. 21PEvaluation of the TruSight Tumor 170 (TST170) assay and its value in clinical research. (16th September 2018) Authors: Heydt, C; Pappesch, R; Stecker, K; Neumann, J; Buettner, R; Merkelbach-Bruse, S Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P11.53.B Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas. (5th September 2022) Authors: Werner, J; Wolf, L; Tscherpel, C; Bauer, E K; Wollring, M; Ceccon, G; Deckert, M; Brunn, A; Pappesch, R; Goldbrunner, R; Fink, G R; Galldiks, N Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗